Catalys Pacific, LLC
Follow13F filer, CIK 2011385, TOKYO, Japan
Catalys Pacific, LLC reported $125,397,981 across 3 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-12.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-116643
- Period
- 2024-09-30
- Reported value
- $125M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| PHATadded | +400,610 | $7.24M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MLYSreduced | -550,000 | -$6.66M |
| HILLEVAX INCreduced | -972,595 | -$1.71M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0001104659-24-116643, largest first. % of portfolio is the value over $125,397,981, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| MLYSMINERALYS THERAPEUTICS INC | 8,644,579 | $105M | 83.48% | -550,000 | Timeline | ||
| PHATPHATHOM PHARMACEUTICALS INC | 1,122,572 | $20.3M | 16.19% | +400,610 | Timeline | ||
| HILLEVAX INCHILLEVAX INC | 236,379 | $416K | 0.33% | -972,595 |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-24-116643 | base | 2024-11-12 | acceptance time not in the bulk data set |